2004
DOI: 10.1152/ajpheart.00183.2004
|View full text |Cite
|
Sign up to set email alerts
|

Contribution of Akt and endothelial nitric oxide synthase to diazoxide-induced late preconditioning

Abstract: Wang, Yigang, Nauman Ahmad, Mitsuhiro Kudo, and Muhammad Ashraf. Contribution of Akt and endothelial nitric oxide synthase to diazoxide-induced late preconditioning. Am J Physiol Heart Circ Physiol 287: H1125-H1131, 2004. First published May 13, 2004; 10.1152/ajpheart.00183.2004.-The opening of mitochondrial ATP-sensitive K ϩ (mitoKATP) channels has a significant role in delayed ischemic preconditioning, and nitric oxide (NO) is a wellknown trigger for its activation. However, the source of NO remains unknown… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
30
0

Year Published

2006
2006
2012
2012

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 39 publications
(32 citation statements)
references
References 25 publications
2
30
0
Order By: Relevance
“…The first study to implicate the PI3K-Akt-p70S6K pathway as an early mediator of delayed IPC, was by Kis and co-workers [89] who demonstrated that administering pharmacological inhibitors of either PI3K or p70S6K prior to IPC, abrogated both the infarct-limiting effects and Akt and p70S6K phosphorylation induced by IPC 24 h later in the rabbit heart. Subsequent studies have confirmed the early mediator role of the PI3K-Akt pathway in delayed preconditioning induced by diazoxide (a mK ATP channel opener) [90] and a δ1 opioid receptor agonist [40], and in the case of the former the Akt downstream target, eNOS, was implicated in the cardioprotective effect [90]. Again, the PIK3-Akt pathway has a bifunctional role by acting as a distal mediator as part of the reperfusion injury salvage kinase pathway [87].…”
Section: The Pi3k-akt Pathwaymentioning
confidence: 91%
“…The first study to implicate the PI3K-Akt-p70S6K pathway as an early mediator of delayed IPC, was by Kis and co-workers [89] who demonstrated that administering pharmacological inhibitors of either PI3K or p70S6K prior to IPC, abrogated both the infarct-limiting effects and Akt and p70S6K phosphorylation induced by IPC 24 h later in the rabbit heart. Subsequent studies have confirmed the early mediator role of the PI3K-Akt pathway in delayed preconditioning induced by diazoxide (a mK ATP channel opener) [90] and a δ1 opioid receptor agonist [40], and in the case of the former the Akt downstream target, eNOS, was implicated in the cardioprotective effect [90]. Again, the PIK3-Akt pathway has a bifunctional role by acting as a distal mediator as part of the reperfusion injury salvage kinase pathway [87].…”
Section: The Pi3k-akt Pathwaymentioning
confidence: 91%
“…phosphorylate and activate eNOS, leading to activation of NO signaling (31,39). Immunblot analysis using total heart homogenates ( Fig.…”
Section: Fig 1 Mbcd Treatment Disrupted Caveolae Structure At the Smentioning
confidence: 99%
“…At the cell membrane, activated IGF-1 receptors stimulate downstream effectors such as PI3-kinase (PI3K) leading to the activation of Akt by phosphorylation [83] and to the accumulation of nuclear phospho-Akt [84,85]. PI3K/Akt phosphorylation of eNOS, a source of cardioprotective and anti-apoptotic NO [86], may provide an additional mechanism through which GH exert anti-apoptotic effect. Interestingly, GH has been shown to induce eNOS expression in endothelial cells [87].…”
Section: Effect Of Gh/igf-1 and Ghs In Regulating Cardiomyocyte Apoptmentioning
confidence: 99%